GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirnaomics Ltd (HKSE:02257) » Definitions » Piotroski F-Score

Sirnaomics (HKSE:02257) Piotroski F-Score : 3 (As of Apr. 22, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Sirnaomics Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sirnaomics has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Sirnaomics's Piotroski F-Score or its related term are showing as below:

HKSE:02257' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 2   Max: 4
Current: 3

During the past 6 years, the highest Piotroski F-Score of Sirnaomics was 4. The lowest was 1. And the median was 2.


Sirnaomics Piotroski F-Score Historical Data

The historical data trend for Sirnaomics's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirnaomics Piotroski F-Score Chart

Sirnaomics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial N/A 4.00 1.00 1.00 3.00

Sirnaomics Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 3.00 1.00 - 3.00

Competitive Comparison of Sirnaomics's Piotroski F-Score

For the Biotechnology subindustry, Sirnaomics's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirnaomics's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirnaomics's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Sirnaomics's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was HK$-399.42 Mil.
Cash Flow from Operations was HK$-153.35 Mil.
Revenue was HK$13.82 Mil.
Gross Profit was HK$9.32 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was (591.881 + 220.213) / 2 = HK$406.047 Mil.
Total Assets at the begining of this year (Dec23) was HK$591.88 Mil.
Long-Term Debt & Capital Lease Obligation was HK$55.25 Mil.
Total Current Assets was HK$151.26 Mil.
Total Current Liabilities was HK$289.37 Mil.
Net Income was HK$-614.56 Mil.

Revenue was HK$0.00 Mil.
Gross Profit was HK$0.00 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was (1276.268 + 591.881) / 2 = HK$934.0745 Mil.
Total Assets at the begining of last year (Dec22) was HK$1,276.27 Mil.
Long-Term Debt & Capital Lease Obligation was HK$59.87 Mil.
Total Current Assets was HK$458.58 Mil.
Total Current Liabilities was HK$101.63 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sirnaomics's current Net Income (TTM) was -399.42. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sirnaomics's current Cash Flow from Operations (TTM) was -153.35. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=-399.421/591.881
=-0.67483329

ROA (Last Year)=Net Income/Total Assets (Dec22)
=-614.561/1276.268
=-0.48152974

Sirnaomics's return on assets of this year was -0.67483329. Sirnaomics's return on assets of last year was -0.48152974. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Sirnaomics's current Net Income (TTM) was -399.42. Sirnaomics's current Cash Flow from Operations (TTM) was -153.35. ==> -153.35 > -399.42 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=55.246/406.047
=0.13605814

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=59.87/934.0745
=0.06409553

Sirnaomics's gearing of this year was 0.13605814. Sirnaomics's gearing of last year was 0.06409553. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=151.263/289.373
=0.52272672

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=458.576/101.629
=4.51225536

Sirnaomics's current ratio of this year was 0.52272672. Sirnaomics's current ratio of last year was 4.51225536. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Sirnaomics's number of shares in issue this year was 77.47. Sirnaomics's number of shares in issue last year was 76.056. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=9.32/13.821
=0.67433616

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0/0
=

Sirnaomics's gross margin of this year was 0.67433616. Sirnaomics's gross margin of last year was . ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=13.821/591.881
=0.02335098

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=0/1276.268
=0

Sirnaomics's asset turnover of this year was 0.02335098. Sirnaomics's asset turnover of last year was 0. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+1+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sirnaomics has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Sirnaomics  (HKSE:02257) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Sirnaomics Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Sirnaomics's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirnaomics Business Description

Traded in Other Exchanges
Address
No.218 Xinghu Street, Unit 415, A4 Building, Suzhou Industrial Park, Suzhou, CHN
Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China.
Executives
Poon Hung Fai 2101 Beneficial owner
Lu Yang 2101 Beneficial owner
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Dai Xiaochang 2201 Interest of corporation controlled by you
Yan Xia Ling 2202 Interest of your spouse
Ceng Yu 2201 Interest of corporation controlled by you
Li Jie 2201 Interest of corporation controlled by you
Li Lele 2202 Interest of your spouse
Shanghai Chongshi Enterprise Management Partnership(lp) 2101 Beneficial owner
Shenzhen Qianhai Rotating Boulder Fund Management Co.,ltd 2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Second Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Third Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you

Sirnaomics Headlines

No Headlines